Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Targovax ASA: Invitation to third quarter 2016 results presentation Thursday 17 November

Posted on: 08 Nov 16

Oslo, Norway, 8 November 2016 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing and commercializing immuno-oncology therapies to target, primarily, treatment-resistant solid tumors, will announce its third quarter 2016 results on Thursday, 17 November 2016. A presentation by Targovax's CEO, Øystein Soug, to investors, analysts and the press will take place in Oslo at 10:00 CET.


The results report and the presentation will be available at in the Investors section from 07:00 CET.



The presentation will take place at 10:00 CET at:


Hotel Continental

Stortingsgaten 24/26

0117 Oslo


The presentation will also be webcast live and can be accessed through


Conference call

At 14:00 CET (08:00 EST) The company will host a telephone conference which will include a presentation of the results, following a Q&A session.  CEO Øystein Soug will present the company.  Call in details can be found below.


Call-in numbers:

Norway Toll-Free Number: 800 19 747

Norway Toll Number: +472350 0559

UK Toll-Free Number: 08082370030

UK Toll Number: +442031394830

US Toll-Free Number: 1866 928 7517

US Toll Number: +1 718 873 9077


Access code: 23804707#


Please make sure to dial in at least 5-10 minutes ahead to complete your registration.


See attached list for more dial-in numbers.




For further information, please contact:

Renate Birkeli, Investor Relations

Phone: +47 922 61 624



Media and IR enquires:

Jan Petter Stiff - Crux Advisers (Norway)

Phone: +47 995 13 891



Julia Phillips/Simon Conway - FTI Consulting (International)

Phone: +44 20 3727 1000


Editor's Details

Mike Wood

Last updated on: 08/11/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.